RLI's combined ratio oscillated across a wide 63.4%-89.2% band over ten quarters and currently sits at 79.0%, but revenue growth reversed from 41.7% in 2024Q3 to -6.3% in 2026Q3 and EPS declined 34.8% year over year, suggesting underwriting retrenchment rather than organic expansion.
RLI Corp. (RLI) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Revenue | 1.94B | 1.88B | 1.77B | 1.51B | 1.7B | 1.18B | 987.68M | 1.01B | 820.36M | 800.8M | 817.85M | 796.47M | 777.12M | 707.73M | 662.71M | 621.38M | 585.63M | 548.55M | 561.01M | 652.35M | 632.71M | 569.3M | 578.8M | 519.89M | 382.15M | 309.35M | 263.5M | 225.76M | 168.11M | 170.5M | 155.35M |
| Revenue Growth % | 4.65% | 6.33% | 17.09% | -10.95% | 43.47% | 19.83% | -1.88% | 22.7% | 2.44% | -2.09% | 2.68% | 2.49% | 9.81% | 6.79% | 6.65% | 6.1% | 6.76% | -2.22% | -14% | 3.1% | 11.14% | -1.64% | 11.33% | 36.04% | 23.53% | 17.4% | 16.72% | 34.29% | -1.4% | 9.75% | -0.86% |
| Medical Costs & Claims | 890.88M | 1.32B | 1.32B | 1.12B | 966.22M | 723.95M | 679.92M | 651.15M | 640.94M | 605.29M | 544.21M | 486.01M | 480.59M | 429.22M | 426.66M | 343.56M | 392.25M | 396.46M | 410.49M | 346.48M | 402.67M | 387.23M | 440.73M | 398.27M | 308.67M | 246.78M | 201.04M | 163.01M | 109.01M | 104.35M | 97.82M |
| Medical Cost Ratio % | 45.87% | 70.18% | 74.32% | 74.15% | 56.9% | 61.17% | 68.84% | 64.69% | 78.13% | 75.59% | 66.54% | 61.02% | 61.84% | 60.65% | 64.38% | 55.29% | 66.98% | 72.27% | 73.17% | 53.11% | 63.64% | 68.02% | 76.14% | 76.61% | 80.77% | 79.77% | 76.3% | 72.21% | 64.84% | 61.2% | 62.96% |
| Gross Profit | 1.05B | 561.42M | 454.63M | 390.87M | 731.77M | 459.6M | 307.76M | 355.47M | 179.43M | 195.51M | 273.64M | 310.46M | 296.53M | 278.51M | 236.05M | 277.81M | 193.38M | 152.09M | 150.52M | 305.87M | 230.04M | 182.07M | 138.07M | 121.61M | 73.49M | 62.57M | 62.46M | 62.75M | 59.1M | 66.15M | 57.54M |
| Gross Margin % | 54.13% | 29.82% | 25.68% | 25.85% | 43.1% | 38.83% | 31.16% | 35.31% | 21.87% | 24.41% | 33.46% | 38.98% | 38.16% | 39.35% | 35.62% | 44.71% | 33.02% | 27.73% | 26.83% | 46.89% | 36.36% | 31.98% | 23.86% | 23.39% | 19.23% | 20.23% | 23.7% | 27.79% | 35.16% | 38.8% | 37.04% |
| Gross Profit Growth % | - | 23.49% | 16.31% | -46.59% | 59.22% | 49.34% | -13.42% | 98.12% | -8.23% | -28.55% | -11.86% | 4.7% | 6.47% | 17.98% | -15.03% | 43.66% | 27.14% | 1.05% | -50.79% | 32.96% | 26.35% | 31.87% | 13.53% | 65.49% | 17.44% | 0.19% | -0.46% | 6.16% | -10.65% | 14.97% | 106.89% |
| Operating Expenses | 547.21M | 43.15M | 27.08M | 13.61M | 11.09M | 115.28M | 117.92M | 122.74M | 111.84M | 110.92M | 116.56M | 113.78M | 107.05M | 102.84M | 93.32M | 94.22M | 14.89M | 19.65M | 43.92M | 51.39M | 43.15M | 38.2M | 37.73M | 27.34M | 24.76M | 21.56M | 24.16M | 19.71M | 21.38M | -55.55M | 22.3M |
| OpEx / Revenue % | 28.18% | 2.29% | 1.53% | 0.9% | 0.65% | 9.74% | 11.94% | 12.19% | 13.63% | 13.85% | 14.25% | 14.29% | 13.77% | 14.53% | 14.08% | 15.16% | 2.54% | 3.58% | 7.83% | 7.88% | 6.82% | 6.71% | 6.52% | 5.26% | 6.48% | 6.97% | 9.17% | 8.73% | 12.72% | -32.58% | 14.35% |
| Depreciation & Amortization | 5.91M | 8.13M | 7.66M | 8.54M | 7.98M | 7.39M | 7.43M | 8.16M | 7.04M | 6.94M | 6.43M | 5.41M | 4.56M | 3.77M | 3.15M | 3.18M | 3.04M | 3.28M | 3.6M | 3.57M | 3.5M | 3.23M | 3.03M | 3.23M | 3.55M | 3.28M | 3.09M | 2.66M | 2.07M | 2.3M | 2.5M |
| Combined Ratio % | 74.05% | 72.47% | 75.85% | 75.05% | 57.56% | 70.91% | 80.78% | 76.88% | 91.76% | 89.44% | 80.79% | 75.31% | 75.62% | 75.18% | 78.46% | 70.45% | 69.52% | 75.86% | 81% | 60.99% | 70.46% | 74.73% | 82.66% | 81.87% | 87.25% | 86.74% | 85.47% | 80.94% | 77.56% | 28.62% | 77.32% |
| Operating Income | 504M | 518.27M | 427.55M | 377.26M | 720.68M | 344.32M | 189.84M | 232.73M | 67.58M | 84.59M | 157.08M | 196.68M | 189.49M | 175.67M | 142.73M | 183.59M | 178.49M | 132.44M | 106.6M | 254.48M | 186.89M | 143.88M | 100.34M | 94.28M | 48.73M | 41.02M | 38.29M | 43.03M | 37.72M | 121.7M | 35.24M |
| Operating Margin % | 25.95% | 27.53% | 24.15% | 24.95% | 42.44% | 29.09% | 19.22% | 23.12% | 8.24% | 10.56% | 19.21% | 24.69% | 24.38% | 24.82% | 21.54% | 29.55% | 30.48% | 24.14% | 19% | 39.01% | 29.54% | 25.27% | 17.34% | 18.13% | 12.75% | 13.26% | 14.53% | 19.06% | 22.44% | 71.38% | 22.68% |
| Operating Income Growth % | - | 21.22% | 13.33% | -47.65% | 109.3% | 81.37% | -18.43% | 244.38% | -20.11% | -46.15% | -20.13% | 3.8% | 7.87% | 23.07% | -22.25% | 2.86% | 34.77% | 24.24% | -58.11% | 36.16% | 29.9% | 43.39% | 6.43% | 93.48% | 18.8% | 7.12% | -11.02% | 14.09% | -69% | 245.35% | -67.46% |
| EBITDA | 514.11M | 526.4M | 435.21M | 385.81M | 728.66M | 351.71M | 197.27M | 240.9M | 74.62M | 91.53M | 163.51M | 202.09M | 194.04M | 179.43M | 145.88M | 186.76M | 181.53M | 135.72M | 110.19M | 258.04M | 190.4M | 147.1M | 103.38M | 97.51M | 52.27M | 44.3M | 41.38M | 45.7M | 39.79M | 124M | 37.74M |
| EBITDA Margin % | 26.47% | 27.96% | 24.58% | 25.52% | 42.91% | 29.72% | 19.97% | 23.93% | 9.1% | 11.43% | 19.99% | 25.37% | 24.97% | 25.35% | 22.01% | 30.06% | 31% | 24.74% | 19.64% | 39.56% | 30.09% | 25.84% | 17.86% | 18.76% | 13.68% | 14.32% | 15.71% | 20.24% | 23.67% | 72.73% | 24.29% |
| Interest Expense | 12.3M | 5.36M | 6.33M | 7.3M | 8.05M | 7.68M | 7.6M | 7.59M | 7.44M | 7.43M | 7.43M | 7.43M | 7.44M | 8.1M | 6.05M | 6.05M | 6.05M | 6.05M | 6.7M | 7M | 6.58M | 7.12M | 6.89M | 1.01M | 1.86M | 3.21M | 5.28M | 4.1M | 2.28M | 1.5M | 2.81M |
| Non-Operating Income | -10.99M | -4.05M | -6.33M | -7.3M | -8.05M | -7.68M | -7.6M | -7.59M | -7.44M | -7.43M | -7.43M | -7.43M | -7.44M | -8.1M | -6.05M | -6.05M | -6.05M | -6.05M | -6.7M | -7M | -6.58M | -7.12M | -6.89M | -1.01M | -1.86M | -3.21M | -5.28M | -4.1M | -2.28M | 120.2M | -2.81M |
| Pretax Income | 491.71M | 505.98M | 427.55M | 377.26M | 720.68M | 344.32M | 189.84M | 232.73M | 67.58M | 84.59M | 157.08M | 196.68M | 189.49M | 175.67M | 142.73M | 183.59M | 178.49M | 132.44M | 106.6M | 254.48M | 186.89M | 143.88M | 100.34M | 94.28M | 48.73M | 41.02M | 38.29M | 43.03M | 37.72M | 41.6M | 35.24M |
| Pretax Margin % | 25.32% | 26.88% | 24.15% | 24.95% | 42.44% | 29.09% | 19.22% | 23.12% | 8.24% | 10.56% | 19.21% | 24.69% | 24.38% | 24.82% | 21.54% | 29.55% | 30.48% | 24.14% | 19% | 39.01% | 29.54% | 25.27% | 17.34% | 18.13% | 12.75% | 13.26% | 14.53% | 19.06% | 22.44% | 24.4% | 22.68% |
| Income Tax | 96.61M | 102.64M | 81.77M | 72.65M | 137.27M | 64.97M | 32.75M | 41.09M | 3.4M | -20.44M | 42.16M | 59.14M | 54.04M | 49.41M | 39.39M | 56.99M | 51.06M | 38.59M | 27.92M | 78.61M | 52.25M | 36.74M | 27.31M | 22.99M | 12.88M | 10.77M | 9.6M | 11.58M | 9.48M | 11.4M | 9.54M |
| Effective Tax Rate % | 19.65% | 20.29% | 19.13% | 19.26% | 19.05% | 18.87% | 17.25% | 17.66% | 5.03% | -24.16% | 26.84% | 30.07% | 28.52% | 28.13% | 27.59% | 31.04% | 28.61% | 29.14% | 26.19% | 30.89% | 27.96% | 25.54% | 27.21% | 24.38% | 26.42% | 26.26% | 25.07% | 26.92% | 25.14% | 27.4% | 27.08% |
| Net Income | 395.1M | 403.34M | 345.78M | 304.61M | 583.41M | 279.35M | 157.09M | 191.64M | 64.18M | 105.03M | 114.92M | 137.54M | 135.44M | 126.25M | 103.35M | 126.6M | 127.43M | 93.84M | 78.68M | 175.87M | 134.64M | 107.13M | 73.04M | 71.29M | 35.85M | 31.05M | 28.69M | 31.45M | 28.24M | 30.2M | 25.7M |
| Net Margin % | 20.34% | 21.43% | 19.53% | 20.15% | 34.36% | 23.6% | 15.91% | 19.04% | 7.82% | 13.12% | 14.05% | 17.27% | 17.43% | 17.84% | 15.59% | 20.37% | 21.76% | 17.11% | 14.02% | 26.96% | 21.28% | 18.82% | 12.62% | 13.71% | 9.38% | 10.04% | 10.89% | 13.93% | 16.8% | 17.71% | 16.54% |
| Net Income Growth % | 11.92% | 16.65% | 13.51% | -47.79% | 108.84% | 77.83% | -18.03% | 198.61% | -38.89% | -8.61% | -16.45% | 1.55% | 7.28% | 22.17% | -18.37% | -0.65% | 35.79% | 19.28% | -55.26% | 30.62% | 25.67% | 46.69% | 2.45% | 98.85% | 15.48% | 8.2% | -8.77% | 11.37% | -6.49% | 17.53% | 225.26% |
| EPS (Diluted) | 4.28 | 4.36 | 3.74 | 3.31 | 6.37 | 3.06 | 1.73 | 2.12 | 0.72 | 1.18 | 1.30 | 1.56 | 1.55 | 1.29 | 1.20 | 1.53 | 1.50 | 1.08 | 0.90 | 1.83 | 1.32 | 1.02 | 0.70 | 0.69 | 0.44 | 0.39 | 0.36 | 0.39 | 0.33 | 0.34 | 0.29 |
| EPS Growth % | 12.6% | 16.58% | 12.99% | -48.04% | 108.17% | 76.88% | -18.4% | 196.5% | -39.41% | -8.88% | -16.99% | 0.97% | 20.23% | 7.08% | -21.31% | 1.67% | 38.89% | 20% | -50.68% | 38.26% | 29.41% | 45.71% | 1.45% | 56.82% | 12.82% | 8.33% | -6.49% | 16.67% | -1.49% | 17.54% | 185% |
| EPS (Basic) | - | 4.38 | 3.78 | 3.34 | 6.43 | 3.09 | 1.75 | 2.14 | 0.72 | 1.19 | 1.31 | 1.56 | 1.57 | 1.47 | 1.22 | 1.55 | 1.52 | 1.09 | 0.92 | 1.87 | 1.35 | 1.06 | 0.73 | 0.71 | 0.45 | 0.40 | 0.37 | 0.39 | 0.34 | 0.37 | 0.33 |
| Diluted Shares Outstanding | 92.25M | 92.22M | 92.45M | 92.15M | 91.59M | 91.42M | 90.75M | 90.51M | 89.67M | 89M | 88.86M | 88.26M | 87.64M | 87.03M | 86.32M | 85.74M | 84.96M | 86.92M | 87.39M | 96.34M | 102.28M | 105.3M | 104.37M | 103.38M | 82.05M | 80.02M | 79.56M | 81.78M | 85.1M | 90.83M | 96.66M |
Quick answers to the most common questions about buying RLI stock.
For fiscal year 2025, RLI Corp. (RLI) reported total revenue of $1.88B. This represents a 1111.7% increase compared to $155.4M in 1996.
RLI Corp. (RLI) is profitable, generating $403.3M in net income for the fiscal year ending 2025 with a net profit margin of 21.4%.
RLI Corp. (RLI) reported an operating income of $518.3M, resulting in an operating profit margin of 27.5%. This margin reflects the operational efficiency of the business before interest and taxes.
RLI Corp. (RLI) generated $561.4M in gross profit for the year, representing a gross profit margin of 29.8%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Casualty social inflation eroding reserves
Metrics are mathematically derived from official filings.
Underwriting Margins Swing Wide
RLI's combined ratio ranged from 63.4% in 2026Q2 to 89.2% in 2024Q4, with the latest quarter at 79.0%, a spread that signals structurally profitable but uneven underwriting across cycles, as compiled from RLI's reported quarterly financial statements.
Every quarter in the ten-period window posted a combined ratio below 100%, implying sustained underwriting profit before any contribution from investment income, yet the 15.6-point move from 63.4% in 2026Q2 to 79.0% in 2026Q3 suggests claims experience rather than expense discipline drove the swing, since the loss ratio alone climbed from 33.0% to 42.2% over the same span. The 63.4% print appears more consistent with an unusually benign loss quarter than a new structural baseline, and investors should resist extrapolating it into forward earnings power. Net operating margin of 27.53% against this combined ratio backdrop indicates pricing discipline, but the volatility implies the margin quality is only as durable as RLI's ability to keep walking away from underpriced casualty business.
Premium Growth Momentum Fades
Revenue growth decelerated from 41.7% year over year in 2024Q3 to -6.3% in 2026Q3, the weakest print in ten quarters, a trajectory that may indicate deliberate underwriting retrenchment rather than lost market share, per the supplied quarterly income statement data.
The growth profile is markedly lumpy — 20.0% in 2025Q2, 4.0% in 2026Q1, 15.2% in 2026Q2, then -6.3% — which suggests quarterly premium recognition is being shaped by renewal timing and portfolio pruning rather than a smooth underlying demand curve. Coupled with casualty premium growth of only 3% in the latest quarter, this pattern appears consistent with a carrier that is prioritizing rate adequacy over volume, exactly the behavior RLI's decentralized product-manager model is designed to produce. Investors should monitor whether the negative growth print persists into 2026Q4, since a sustained contraction would begin to erode the fixed-cost absorption that supports the current expense base.
Loss Ratio Compression Warrants Scrutiny
RLI's loss ratio fell from 85.4% in 2024Q4 to 33.0% in 2026Q2 before rebounding to 42.2%, a 52-point compression that appears too large to reflect current-year pricing alone and may point to prior-year reserve releases flattering calendar-year earnings, based on RLI's disclosed figures.
Claims and benefits expense dropped from $374.9M in 2024Q4 to $189.9M in 2026Q2 while revenue rose modestly, a combination that is difficult to attribute solely to underwriting improvement and warrants separating accident-year results from calendar-year development. If a meaningful portion of the improvement stems from releases on older casualty vintages, then reported operating income of $210.7M in 2026Q2 may overstate the profitability of the business actually being written today. Given persistent social inflation in commercial auto, investors should treat favorable development as potentially reversible and demand accident-year loss ratios before underwriting the current margin quality.
2024Q4 Marks Earnings Trough
As reported by RLI, 2024Q4 marked the ten-quarter earnings trough, with operating income of just $47.4M, diluted EPS of $0.44 down 64.8%, and a combined ratio of 89.2%, before a rapid recovery through 2025.
The trough pairs the series' lowest operating income with its highest combined ratio and lowest revenue growth of the early window, appearing consistent with a concentrated period of elevated property losses rather than broad structural decay, given that the combined ratio recovered to 68.7% by 2025Q2. The subsequent swing to $168.0M of net income and $1.82 EPS in 2026Q2 implies substantial underwriting operating leverage, where a roughly 16-point combined ratio improvement produced a fourfold EPS increase versus the trough. That leverage cuts both ways, however: the same sensitivity suggests modest deterioration in loss experience could compress earnings quickly, making the trough a useful stress benchmark for downside modeling rather than a distant anomaly.
Earnings Quality Beyond Underwriting
RLI's 2026Q3 net income of $81.0M fell 34.8% year over year even though its 79.0% combined ratio remained comfortably below 100%, a divergence that suggests reported earnings may be increasingly sensitive to items outside core underwriting, according to RLI's quarterly results.
A 79.0% combined ratio should ordinarily support healthier bottom-line conversion, so the 34.8% EPS decline implies either elevated catastrophe burden, softer fee or investment contributions, or reserve movements that are not visible in the summary table; net investment income and yield columns are unavailable in the supplied data, which warrants further investigation before attributing the miss. Counter-argument to the bull case: the market may be underappreciating that RLI's specialty casualty book, the primary volume driver, sits directly in the path of social inflation, where litigation cost trends could eventually force adverse development that reverses recent releases. Additionally, with the debt-to-equity ratio at 0.06%, the fortress balance sheet that supports special dividends may simultaneously cap ROE relative to more levered peers such as Kinsale or Arch, meaning part of RLI's valuation premium rests on consistency of underwriting alpha that the volatile quarterly EPS record does not fully corroborate.